Reckitt Benckiser Group (LON:RB) Price Target Cut to GBX 5,000 by Analysts at Royal Bank of Canada
Reckitt Benckiser Group (LON:RB) had its target price trimmed by Royal Bank of Canada from GBX 5,300 ($69.72) to GBX 5,000 ($65.77) in a report published on Friday, Stock Target Advisor reports. The brokerage currently has an underperform rating on the stock.
A number of other brokerages have also recently weighed in on RB. Barclays reissued a buy rating and set a GBX 7,400 ($97.34) target price on shares of Reckitt Benckiser Group in a report on Thursday. Societe Generale dropped their target price on shares of Reckitt Benckiser Group from GBX 5,500 ($72.35) to GBX 5,300 ($69.72) and set a sell rating on the stock in a report on Tuesday, November 26th. UBS Group reissued a neutral rating and set a GBX 6,100 ($80.24) target price on shares of Reckitt Benckiser Group in a report on Thursday. Jefferies Financial Group reissued a sell rating and set a GBX 5,000 ($65.77) target price on shares of Reckitt Benckiser Group in a report on Thursday. Finally, JPMorgan Chase & Co. dropped their target price on shares of Reckitt Benckiser Group from GBX 8,500 ($111.81) to GBX 7,700 ($101.29) and set an overweight rating on the stock in a report on Friday. Four investment analysts have rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the company. The company has a consensus rating of Hold and a consensus price target of GBX 6,533.53 ($85.94).
RB traded down GBX 120 ($1.58) during trading on Friday, hitting GBX 5,721 ($75.26). The company had a trading volume of 3,311,255 shares, compared to its average volume of 1,720,000. The company has a market cap of $40.60 billion and a PE ratio of 28.72. Reckitt Benckiser Group has a 1-year low of GBX 5,510 ($72.48) and a 1-year high of GBX 8,191.30 ($107.75). The business has a 50-day moving average of GBX 6,258.26 and a 200-day moving average of GBX 6,141.32. The company has a debt-to-equity ratio of 85.08, a current ratio of 0.59 and a quick ratio of 0.43.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Article: Overbought
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.